Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0ZI0C
|
||||
Former ID |
DIB007781
|
||||
Drug Name |
Dersalazine
|
||||
Synonyms |
UR-12715; UR-12746
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Inflammatory bowel disease [ICD9: 555, 556; ICD10:K50, K51] | Phase 2 | [1] | ||
Company |
Grupo Uriach
|
||||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C35H31N6NaO4
|
||||
Canonical SMILES |
n1(c(nc2c1ccnc2)C)CC1CCN(C(=O)/C=C(\c2ccc(/N=N/c3cc(C(=<br />O)O)c(cc3)O)cc2)/c2ccccc2)CC1
|
||||
CAS Number |
CAS 188913-58-8
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Platelet-activating factor receptor | Target Info | Inhibitor | [1] | |
KEGG Pathway | Calcium signaling pathway | ||||
Neuroactive ligand-receptor interaction | |||||
Staphylococcus aureus infection | |||||
NetPath Pathway | IL5 Signaling Pathway | ||||
Leptin Signaling Pathway | |||||
Reactome | Class A/1 (Rhodopsin-like receptors) | ||||
G alpha (q) signalling events | |||||
Interferon gamma signaling | |||||
WikiPathways | GPCRs, Class A Rhodopsin-like | ||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
Small Ligand GPCRs | |||||
Interferon gamma signaling | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
References | |||||
REF 1 | The intestinal anti-inflammatory effect of dersalazine sodium is related to a down-regulation in IL-17 production in experimental models of rodent colitis. Br J Pharmacol. 2012 February; 165(3): 729-740. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.